Your session is about to expire
← Back to Search
Epidural fentanyl /spinal bupivacaine for Labor Pain
Study Summary
This trial will compare the effect of epidural fentanyl vs. intrathecal fentanyl on the rate of fetal bradycardia in parturients during labor.
- Labor Pain
- Obstetric Pain
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The mother has a high body temperature.You are allergic to certain numbing medications or fentanyl.You are experiencing rapid uterine contractions before receiving pain relief medication in your spine.You do not want to take part in the study.You are full-term in your pregnancy, meaning you have reached 37 weeks or more.A specific anesthesia method called "combined spinal-epidural" will not be used.You cannot have a specific type of anesthesia called neuraxial technique.You are experiencing itching before receiving a certain type of pain relief.You are not currently experiencing any pregnancy-related health problems.
- Group 1: Spinal Bupivacaine
- Group 2: Spinal Fentanyl
- Group 3: Spinal Fentanyl and Bupivacaine
- Group 4: Epidural fentanyl /spinal bupivacaine
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has there been any past research conducted utilizing Epidural fentanyl and spinal bupivacaine?
"Presently, 141 clinical trials are in progress evaluating Epidural fentanyl /spinal bupivacaine with 26 studies taking place at Phase 3. Primarily conducted near Germantown, Tennessee, these investigations into Epidural fentanyl /spinal bupivacaine have spread to 204 distinct sites across the globe."
What medical conditions have been addressed with Epidural fentanyl /spinal bupivacaine?
"Epidural fentanyl/spinal bupivacaine is commonly administered to treat pemphigus, in addition to acute nonspecific tenosynovitis, general anesthesia, and lupus erythematosus cell."
Is the research team actively recruiting participants for this experiment?
"This clinical trial is currently recruiting participants, as per information provided on the website of clinicaltrials.gov. The study was first released on October 28th 2019 and has undergone its most recent update July 21st 2021."
How many participants are accepted for the current clinical trial?
"Affirmative. Clinicaltrials.gov denotes that the study, initially unveiled on October 28th 2019, requires 558 subjects from 1 clinical trial centre and is actively recruiting participants."
Is the blend of epidural fentanyl and spinal bupivacaine sanctioned by the Food & Drug Administration?
"The safety of epidural fentanyl and spinal bupivacaine is rated highly, receiving a score of 3. This treatment being in Phase 4 signifies that it has been approved by the relevant authorities after multiple rounds of data collection and analysis."
Share this study with friends
Copy Link
Messenger